RA Capital's stake was diluted by the company's share issuance, not by selling. The pre-funded warrant blocker at 9.99% means RA Capital cannot increase its voting stake above that threshold without a blocker amendment. Monitor for any future amendment that removes the blocker, which would signal intent to exercise warrants and increase exposure.
SLDB drugs
SLDB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $7.02entry
- T+1 · 7d ago +2.14%α +2.50% · $7.17
- T+5 · 20h ago −7.69%α −6.00% · $6.48
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
RA Capital Management filed Amendment No. 14 to its Schedule 13D for Solid Biosciences, reporting a dilution of its beneficial ownership stake from a prior level to 10.8% (12,036,126 shares including pre-funded warrants). The filing states the change is solely due to share issuance by the company, not any acquisition or disposition by RA Capital. RA Capital holds pre-funded warrants for 8,178,412 additional shares but is blocked from exercising them due to a 9.99% beneficial ownership blocker.
Key Financial Metrics
Key Facts
- RA Capital Management reports beneficial ownership of 12,036,126 shares (10.8% of common stock) as of November 4, 2026
- Stake includes 11,897,896 shares held by RA Capital Healthcare Fund, 109,661 shares by Nexus Fund, 28,569 shares by a managed account, plus pre-funded warrants for 8,178,412 shares
- Pre-funded warrants are subject to a 9.99% beneficial ownership blocker, preventing exercise
- Dilution is attributed to share issuance by Solid Biosciences, not RA Capital trading activity
- No transactions in the past 60 days by the reporting persons
- Percentage based on 111,610,531 shares outstanding as of October 30, 2026 per the company's 10-Q
Financial Impact
RA Capital's voting/economic stake diluted from prior level to 10.8% due to company share issuance; pre-funded warrant overhang of 8.18M shares remains blocked
Risk Factors
- Dilution from share issuance could continue if the company raises additional capital
- Pre-funded warrant overhang of 8.18M shares (7.3% of outstanding) could be exercised if blocker is amended, adding selling pressure or signaling activist escalation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001346824-26-000255 |
| Document: 0001346824-26-000255-index.html | 0001346824-26-000255 |
| Document: 0001346824-26-000255.txt | 0001346824-26-000255 |
Track record
14 reports on SLDB
5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +20.77% at T+20 after the Mar 19, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $6.84 Now $6.48 −5.26% settles Dec 15
- Nov 6, 202610d ago SC 13D/A Neutral 3/10 Viewing Entry $7.02 Now $6.48 −7.69% settles Dec 8
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $6.18 Now $6.48 +4.85% settles Dec 4
- Aug 6, 202614w ago S-3ASR Neutral 4/10 Entry $8.39 to $10.25 Now $6.48 −22.77% ▲ +22.17% +22.57% vs SPY
- May 12, 202626w ago Press Release Bearish 6/10 Entry $7.38 to $7.22 Now $6.48 +12.20% ▲ +2.17% +1.56% vs SPY
- May 7, 202627w ago Press Release Bullish 7/10 Entry $7.07 to $6.85 Now $6.48 −8.35% ▼ −3.11% −6.25% vs SPY
- Apr 23, 202629w ago DEFA14A Neutral 3/10 Entry $7.92 to $6.50 Now $6.48 −18.18% ▼ −17.93% −21.96% vs SPY
- Apr 10, 202631w ago 8-K Neutral 2/10 Entry $8.39 to $7.68 Now $6.48 −22.77% ▼ −8.46% −16.19% vs SPY
- Apr 1, 202632w ago EFFECT Bearish 7/10 Entry $7.38 to $7.05 Now $6.48 +12.20% ▲ +4.47% +14.19% vs SPY
- Mar 19, 202634w ago Press Release Bullish 8/10 Entry $7.03 to $8.49 Now $6.48 −7.82% ▲ +20.77% +11.45% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers